GLAXOSMITHKLINE(GSK.UK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

GSK.UK GLAXOSMITHKLINE

Market Closed 05-10 16:30:00 BST Delay

1,799.50

+19.00

+1.07%

High1,799.50	Low1,780.00	Vol4.10M
Open1,784.00	D1 Closing1,780.50	Amplitude1.10%
Mkt Cap7.34T	Tradable Cap7.07T	Total Shares4.08B
T/O7.36B	T/O Rate0.10%	Tradable Shares3.93B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"GSK.UK","market":"UK","secType":"STK","nameCN":"GLAXOSMITHKLINE","latestPrice":1799.5,"timestamp":1715355000000,"preClose":1780.5,"halted":0,"volume":4095522,"delay":15,"nameEN":"GLAXOSMITHKLINE","floatShares":3930952742,"shares":4078037355,"eps":108.8578,"marketStatus":"Market Closed","change":19,"latestTime":"05-10 16:30:00 BST Delay","open":1784,"high":1799.5,"low":1780,"amount":7359923919,"amplitude":0.010952,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":108.8578,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1715583600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"LSE","adjPreClose":1780.5,"openAndCloseTimeList":[[1715324400000,1715355000000]],"volumeRatio":0.8751165124498939,"tradeCurrency":"GBX","tradeService":"SETS","exchangeMarketSize":1000},"requestUrl":"/m/hq/s/GSK.UK","defaultTab":"news","newsList":[{"id":"2434859216","title":"FDA Delays 'Important' Moderna Vaccine Review: William Blair Says 2025 Growth, '2026 Breakeven Story' Depends On It","url":"https://stock-news.laohu8.com/highlight/detail?id=2434859216","media":"Benzinga","top":-1,"share":"https://ttm.financial/m/news/2434859216?lang=en_us&edition=fundamental","pubTime":"2024-05-10 21:27","pubTimestamp":1715347625,"startTime":"0","endTime":"0","summary":"FDA update: Moderna&#39;s BLA for mRNA-1345, RSV vaccine, may face delay past May 12 deadline. But no safety concerns reported.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/general/biotech/24/05/38760678/fda-delays-important-moderna-vaccine-review-william-blair-says-2025-growth-2026-breakeven-story-d","is_publish_highlight":false,"gpt_icon":0},{"id":"2434859053","title":"Dynavax: HEPLISAV-B Growth Up, Pipeline Uncertain","url":"https://stock-news.laohu8.com/highlight/detail?id=2434859053","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2434859053?lang=en_us&edition=fundamental","pubTime":"2024-05-10 21:02","pubTimestamp":1715346133,"startTime":"0","endTime":"0","summary":"HEPLISAV-B Q1 revenue was $48 million, showing 10% YoY growth.Dynavax's shingles and Tdap vaccines advanced in clinical stages, with data anticipated in the coming quarters.Dynavax's balance sheet rem","market":"sg","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1316007813/image_1316007813.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1316007813/image_1316007813.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/article/4691803-dynavax-heplisav-b-growth-up-pipeline-uncertain","is_publish_highlight":false,"gpt_icon":0},{"id":"2434285320","title":"FDA Delays Decision on Moderna RSV Shot by 3 Weeks -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2434285320","media":"Dow Jones","top":-1,"share":"https://ttm.financial/m/news/2434285320?lang=en_us&edition=fundamental","pubTime":"2024-05-10 20:26","pubTimestamp":1715343960,"startTime":"0","endTime":"0","summary":"The Food and Drug Administration has pushed back the release of its decision on approval of Moderna's respiratory syncytial virus vaccine by up to three weeks due to \"administrative constraints,\" the company said early Friday.The FDA was originally scheduled to announce a decision on Sunday. It now says it will decide by the end of May, according to Moderna. The company said that the FDA hadn't flagged any issues with the drug's safety, efficacy, or quality, and that the delay was purely administrative.Moderna shares were off 2.2% early Friday. The stock has risen 23% so far this year as investors have looked ahead to the launch of the RSV shot. It is set to be the company's second product after the Covid-19 vaccine it launched in late 2020.In a note early Friday, William Blair analyst Myles Minter wrote that delays are \"disappointing,\" but that he still expects the drug will be approved.Analysts have been generally optimistic about the FDA giving the go-ahead for the shot. Jefferies a","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"gpt_icon":0},{"id":"2434836555","title":"Merck: The Worst Has Been Avoided (Rating Upgrade)","url":"https://stock-news.laohu8.com/highlight/detail?id=2434836555","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2434836555?lang=en_us&edition=fundamental","pubTime":"2024-05-10 18:02","pubTimestamp":1715335361,"startTime":"0","endTime":"0","summary":"On April 25, one of the leaders in the global oncology drugs market published extremely positive financial results for the first quarter of 2024.Keytruda sales were about $6.95 billion in the first qu","market":"hk","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1337117159/image_1337117159.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1337117159/image_1337117159.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/article/4691766-merck-stock-q1-earnings-worst-has-been-avoided-rating-upgrade-buy","is_publish_highlight":false,"gpt_icon":0},{"id":"2434406242","title":"Moderna’s mRNA Dreams Meet Reality With First Post-Covid Shot","url":"https://stock-news.laohu8.com/highlight/detail?id=2434406242","media":"Bloomberg","top":-1,"share":"https://ttm.financial/m/news/2434406242?lang=en_us&edition=fundamental","pubTime":"2024-05-09 18:00","pubTimestamp":1715248832,"startTime":"0","endTime":"0","summary":" -- Moderna Inc.’s pioneering Covid shot turned the company into a nearly $200 billion biotech giant and a public health hero. Its second vaccine, meant to prevent a common respiratory virus, is calling into question the premise on which the company has staked its entire business.Microsoft’s XboxIs Planning More Cuts After Studio Closings. Americans AreRackingUp‘Phantom Debt’ That Wall Street Can’t Track. Stormy Daniels Will Return to Court in Test of Trump’s Demeanor. The forthcoming RSV shot, expected to get US regulatory approval this month, is Moderna’s first chance to show the versatility of mRNA technology to more effectively treat andprevent a range of illnesses from the flu to cancer. It will be the first mRNA product for something other than Covid.Most drugmakers don’t stake their business on a single scientific approach. Even BioNTech SE, which developed with Pfizer anmRNA-powered","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/zf5C8d67MsNzkAY8PV87gA--~B/aD03ODg7dz0xMjk2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/bloomberg_markets_842/9ae8c4d294c6373508ad05a0ae644ec7","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/zf5C8d67MsNzkAY8PV87gA--~B/aD03ODg7dz0xMjk2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/bloomberg_markets_842/9ae8c4d294c6373508ad05a0ae644ec7"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/moderna-mrna-dreams-meet-reality-100032918.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2434058710","title":"GSK (LON:GSK) Is Paying Out A Dividend Of £0.15","url":"https://stock-news.laohu8.com/highlight/detail?id=2434058710","media":"Simply Wall St.","top":-1,"share":"https://ttm.financial/m/news/2434058710?lang=en_us&edition=fundamental","pubTime":"2024-05-09 13:37","pubTimestamp":1715233047,"startTime":"0","endTime":"0","summary":"GSK plc's  investors are due to receive a payment of 0.15 per share on 11th of July. The dividend yield will be 3.3% based on this payment which is still above the industry average.While it is great to have a strong dividend yield, we should also consider whether the payment is sustainable. Prior to this announcement, GSK's dividend was comfortably covered by both cash flow and earnings. This indicates that a lot of the earnings are being reinvested into the business, with the aim of fueling growth.The next year is set to see EPS grow by 62.2%. If the dividend continues on this path, the payout ratio could be 32% by next year, which we think can be pretty sustainable going forward.Although the company has a long dividend history, it has been cut at least once in the last 10 years. The dividend has gone from an annual total of 0.975 in 2014 to the most recent total annual payment of 0.58. Doing the maths, this is a decline of about 5.1% per year. A company that decreases its dividend ov","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/sD871knG1Uc7O_uc1EPUcA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/a99782b24065c2e10ff5cc21f6727f48","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/sD871knG1Uc7O_uc1EPUcA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/a99782b24065c2e10ff5cc21f6727f48"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/gsk-lon-gsk-paying-dividend-053727741.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2434770542","title":"GSK’s 24th AGM Sees High Approval Rates","url":"https://stock-news.laohu8.com/highlight/detail?id=2434770542","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2434770542?lang=en_us&edition=fundamental","pubTime":"2024-05-09 02:57","pubTimestamp":1715194648,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline (GSK) has released an update. GlaxoSmithKline plc successfully conducted its 24th Annual General Meeting (AGM) with shareholders pa...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-24th-agm-sees-high-approval-rates?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-24th-agm-sees-high-approval-rates?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2434772394","title":"GSK Announces Key Board Committee Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2434772394","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2434772394?lang=en_us&edition=fundamental","pubTime":"2024-05-09 01:57","pubTimestamp":1715191071,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline (GSK) has released an update. GlaxoSmithKline (GSK) has announced changes to its Board Committee, with Wendy Becker joining the Cor...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-announces-key-board-committee-changes?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-announces-key-board-committee-changes?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2434774654","title":"GSK Shareholders Display Strong Confidence at AGM","url":"https://stock-news.laohu8.com/highlight/detail?id=2434774654","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2434774654?lang=en_us&edition=fundamental","pubTime":"2024-05-09 01:47","pubTimestamp":1715190442,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline plc (UK) (GB:GSK) has released an update. GlaxoSmithKline plc successfully conducted its 24th Annual General Meeting (AGM) with sha...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-shareholders-display-strong-confidence-at-agm?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-shareholders-display-strong-confidence-at-agm?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2434776435","title":"GSK Announces Board Committee Appointments","url":"https://stock-news.laohu8.com/highlight/detail?id=2434776435","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2434776435?lang=en_us&edition=fundamental","pubTime":"2024-05-09 00:27","pubTimestamp":1715185635,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline plc (UK) (GB:GSK) has released an update. GlaxoSmithKline plc has announced that Wendy Becker has joined the Corporate Responsibili...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-announces-board-committee-appointments?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-announces-board-committee-appointments?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2433874459","title":"Innoviva to Participate in the BofA Securities Health Care Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2433874459","media":"Business Wire","top":-1,"share":"https://ttm.financial/m/news/2433874459?lang=en_us&edition=fundamental","pubTime":"2024-05-08 19:00","pubTimestamp":1715166000,"startTime":"0","endTime":"0","summary":"BURLINGAME, Calif., May 08, 2024----Innoviva, Inc.  , a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease platform known as Innoviva Specialty Therapeutics , and a portfolio of strategic investments in healthcare assets, today announced that Pavel Raifeld, Chief Executive Officer, will present at the BofA Securities Health Care Conference in Las Vegas, NV on Wednesday, May 15, 2024 at 9:20 a.m. Pacific Daylight Time.ANORO, RELVAR, BREO and TRELEGY are trademarks of the GSK group of companies.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/cgl_KwdSJNmaEkYISJpW3w--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/55a6525e100b75029152eba8a5acfe1c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/cgl_KwdSJNmaEkYISJpW3w--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/55a6525e100b75029152eba8a5acfe1c"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/innoviva-participate-bofa-securities-health-110000983.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2433221049","title":"BRIEF-Bioversys Announces Expansion Of Strategic Collaboration With GSK And Extension Of Its Series C Round By CHF 12.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2433221049","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2433221049?lang=en_us&edition=fundamental","pubTime":"2024-05-07 14:30","pubTimestamp":1715063436,"startTime":"0","endTime":"0","summary":"May 7  - Bioversys:   * BIOVERSYS ANNOUNCES EXPANSION OF STRATEGIC COLLABORATION WITH GSK AND EXTENSION OF ITS SERIES C ROUND BY CHF 12.3 MILLION   * BIOVERSYS : STRATEGIC COLLABORATION WITH GSK EXPANDED TO ACCELERATE CLINICAL DEVELOPMENT OF ALPIBECTIR FOR TREATMENT OF TUBERCULOSIS   * BIOVERSYS: GSK TO PARTICIPATE IN SERIES C EXTENSION WITH EQUITY INVESTMENT   * BIOVERSYS: SERIES C FINANCING ROUND EXTENDED OVERALL BY CHF 12.3 MILLION TO CHF 44.9 MILLIONFurther company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2433338211","title":"BioVersys Announces Expansion of Strategic Collaboration With GSK and Extension of Its Series C Round by CHF 12.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2433338211","media":"GlobeNewswire","top":-1,"share":"https://ttm.financial/m/news/2433338211?lang=en_us&edition=fundamental","pubTime":"2024-05-07 13:00","pubTimestamp":1715058000,"startTime":"0","endTime":"0","summary":"Strategic collaboration with GSK expanded to accelerate clinical development of alpibectir for the treatment of tuberculosis. GSK to participate in Series C Extension with equity investment. BASEL, Switzerland, May 07, 2024  -- BioVersys AG, a multi-asset, clinical stage biopharmaceutical company focusing on research and development of novel antibacterial products for serious life-threatening infections caused by multi-drug resistant  bacteria, announced today the expansion of its strategic collaboration with the global biopharma company GSK plc  to accelerate the clinical development of alpibectir  for the treatment of tuberculosis .GSK and BioVersys will continue their collaboration beyond the current Phase 2a and develop alpibectir in both TB pulmonary and TB meningitis programs in order to make alpibectir available to patients as soon as possible.Thomas Breuer, Chief Global Health Officer, GSK: \"GSK is committed to changing the trajectory of tuberculosis and we’re excited to expand","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/_Azeu3tRQOLUkzNjy_Avkg--~B/aD0zNDQ7dz0xNTk4O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/1c3f5cc4e59ab90e535e1babc8b81e14","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/_Azeu3tRQOLUkzNjy_Avkg--~B/aD0zNDQ7dz0xNTk4O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/1c3f5cc4e59ab90e535e1babc8b81e14"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bioversys-announces-expansion-strategic-collaboration-050000549.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2432185152","title":"Vir Biotechnology Provides Some Hope For Its Beleaguered Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2432185152","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2432185152?lang=en_us&edition=fundamental","pubTime":"2024-05-04 00:47","pubTimestamp":1714754826,"startTime":"0","endTime":"0","summary":"Vir Biotechnology, Inc. reported its first-quarter earnings after the bell on Thursday, giving its shareholders some positive tidbits.The company continues to have a cash balance higher than the stock","market":"sg","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1175270464/image_1175270464.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1175270464/image_1175270464.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/article/4689136-vir-biotechnology-provides-some-hope-for-its-beleaguered-shareholders","is_publish_highlight":false,"gpt_icon":0},{"id":"2432016619","title":"GSK Executive Sells Shares on London Exchange","url":"https://stock-news.laohu8.com/highlight/detail?id=2432016619","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2432016619?lang=en_us&edition=fundamental","pubTime":"2024-05-03 22:48","pubTimestamp":1714747703,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline plc (UK) (GB:GSK) has released an update. GlaxoSmithKline plc announces an insider transaction involving the sale of 6,000 ordinary...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-executive-sells-shares-on-london-exchange?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-executive-sells-shares-on-london-exchange?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2432562904","title":"How to Maximize Your Retirement Portfolio with These Top-Ranked Dividend Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2432562904","media":"Zacks","top":-1,"share":"https://ttm.financial/m/news/2432562904?lang=en_us&edition=fundamental","pubTime":"2024-05-03 21:10","pubTimestamp":1714741802,"startTime":"0","endTime":"0","summary":"Strange but true: seniors fear death less than running out of money in retirement.And older Americans have legitimate reasons for this worry, even if they have dutifully saved for their golden years. That's because the traditional ways people manage retirement may no longer provide enough income to meet expenses - and with people generally living longer, the principal retirement savings is exhausted far too early in the retirement period.The tried-and-true retirement investing approach of yesterday doesn't work today.For many years, bonds or other fixed-income assets could produce the yield needed to provide solid income for retirement needs. However, these yields have dwindled over time: 10-year Treasury bond rates in the late 1990s were around 6.50%, but today, that rate is a thing of the past, with a slim likelihood of rates making a comeback in the foreseeable future.And lower bond yields aren't the only potential problem seniors are facing. Today's retirees aren't feeling as secur","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/M2z0wFqvnPw7eaLU0tPuyQ--~B/aD02MzY7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/0c6f98f4bf655bec3b199bc1a71b8b85","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/M2z0wFqvnPw7eaLU0tPuyQ--~B/aD02MzY7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/0c6f98f4bf655bec3b199bc1a71b8b85"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/maximize-retirement-portfolio-top-ranked-131002995.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2432932879","title":"GSK knew about Zantac cancer risk, attorneys tell jury in first trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2432932879","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2432932879?lang=en_us&edition=fundamental","pubTime":"2024-05-03 02:57","pubTimestamp":1714676246,"startTime":"0","endTime":"0","summary":"By Diana Novak Jones      May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that phar","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2432993572","title":"Moderna to seek parity for RSV shot as rivals lead in market","url":"https://stock-news.laohu8.com/highlight/detail?id=2432993572","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2432993572?lang=en_us&edition=fundamental","pubTime":"2024-05-03 01:48","pubTimestamp":1714672131,"startTime":"0","endTime":"0","summary":"With its Q1 2024 financials on Thursday, Moderna (NASDAQ:MRNA) highlighted its upcoming RSV vaccine, noting that the company expects U.S. regulators to recommend its messenger-RNA-based shot on par wi","market":"nz","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1730228397/image_1730228397.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1730228397/image_1730228397.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4099014-moderna-to-seek-parity-for-rsv-shot-as-rivals-lead-in-market","is_publish_highlight":false,"gpt_icon":0},{"id":"2432667812","title":"Moderna posts better-than-expected quarterly results as it looks to fall RSV vaccine launch","url":"https://stock-news.laohu8.com/highlight/detail?id=2432667812","media":"Dow Jones","top":-1,"share":"https://ttm.financial/m/news/2432667812?lang=en_us&edition=fundamental","pubTime":"2024-05-02 18:33","pubTimestamp":1714645980,"startTime":"0","endTime":"0","summary":"First-quarter loss is narrower than expected despite plunging COVID vaccine sales. Moderna Inc. on Thursday reported a narrower-than-expected first-quarter loss as the COVID vaccine maker looks to launch its second product in the U.S. later this year.Moderna  reiterated its full-year 2024 guidance of $4 billion in product sales, which includes projected COVID vaccine revenues as well as sales of a new respiratory syncytial virus vaccine that the company hopes to launch in time for the fall vaccination season.More than 60% of Moderna employees are now using ChatGPT, Chief Financial Officer Jamey Mock told MarketWatch, and the company has over 750 GPTs, the large language models that can create human-like content and perform a broad array of tasks. \"That has enabled so much productivity,\" Mock said.Moderna also now has 10 late-stage products in its pipeline, Mock said, across respiratory, latent viruses, rare disease and other therapeutic areas.The company said at a March investor event ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.gsk.com","stockEarnings":[{"period":"1week","weight":0.0381},{"period":"1month","weight":0.1101},{"period":"3month","weight":0.0946},{"period":"6month","weight":0.3125},{"period":"1year","weight":0.2961},{"period":"ytd","weight":0.2529}],"compareEarnings":[{"period":"1week","weight":0.0275},{"period":"1month","weight":0.0644},{"period":"3month","weight":0.1293},{"period":"6month","weight":0.1654},{"period":"1year","weight":0.1309},{"period":"ytd","weight":0.105}],"compareStock":{"symbol":"ISF.UK","name":"FTSE100 ETF"},"description":"GSK plc, together with its subsidiaries, engages in the research, development and manufacture of vaccines and specialty medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as infectious disease, HIV, immunology and respiratory, and oncology. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is based in Brentford, the United Kingdom.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.013575},{"month":2,"riseRate":0.541667,"avgChangeRate":-0.00121},{"month":3,"riseRate":0.625,"avgChangeRate":0.009039},{"month":4,"riseRate":0.75,"avgChangeRate":0.03211},{"month":5,"riseRate":0.416667,"avgChangeRate":-0.008892},{"month":6,"riseRate":0.565217,"avgChangeRate":0.005689},{"month":7,"riseRate":0.478261,"avgChangeRate":-0.002688},{"month":8,"riseRate":0.521739,"avgChangeRate":-0.003921},{"month":9,"riseRate":0.565217,"avgChangeRate":-0.000863},{"month":10,"riseRate":0.434783,"avgChangeRate":-0.000676},{"month":11,"riseRate":0.391304,"avgChangeRate":-0.007441},{"month":12,"riseRate":0.608696,"avgChangeRate":0.015835}],"exchange":"LSE","name":"GLAXOSMITHKLINE","nameEN":"GLAXOSMITHKLINE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GLAXOSMITHKLINE(GSK.UK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest GLAXOSMITHKLINE(GSK.UK) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"GLAXOSMITHKLINE,GSK.UK,GLAXOSMITHKLINE股票,GLAXOSMITHKLINE股票老虎,GLAXOSMITHKLINE股票老虎国际,GLAXOSMITHKLINE行情,GLAXOSMITHKLINE股票行情,GLAXOSMITHKLINE股价,GLAXOSMITHKLINE股市,GLAXOSMITHKLINE股票价格,GLAXOSMITHKLINE股票交易,GLAXOSMITHKLINE股票购买,GLAXOSMITHKLINE股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GLAXOSMITHKLINE(GSK.UK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest GLAXOSMITHKLINE(GSK.UK) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction